Stockreport

Immunovant Awarded U.S. Patent for IMVT-1402 [Yahoo! Finance]

Immunovant, Inc.  (IMVT) 
PDF NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT) , a clinical-stage immunology company dedicated to enabling normal lives for people with au [Read more]